These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 610543)

  • 1. Serum thyroglobulin levels in patients with differentiated thyroid carcinoma.
    Van Herle AJ
    Ann Radiol (Paris); 1977; 20(8):743-5. PubMed ID: 610543
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
    Herle AJ; Uller RP
    J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyroglobulin determinations in patients with differentiated thyroid carcinoma.
    Bednár J; Nĕmec J; Zamrazil V; Vána S; Pohunková D; Röhling S
    Nuklearmedizin; 1983 Aug; 22(4):204-11. PubMed ID: 6634419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum thyroglobulin (S-hTG): a tumor marker in patients with differentiated thyroid carcinoma (author's transl)].
    Jänsch A; Heinze HG; Hast B
    Strahlentherapie; 1981 Jun; 157(6):381-92. PubMed ID: 7256806
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum thyroglobulin in differentiated thyroid carcinoma.
    Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
    Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thyroglobulin measurements in differentiated thyroid cancer.
    Girelli ME; De Vido D
    Biomed Pharmacother; 2000 Jul; 54(6):330-3. PubMed ID: 10989968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral markers for thyroid carcinoma.
    Pacini F; Martino E; Bambini G; Aghini-Lombardi F; Taddei D; Lari R; Pinchera A; Baschieri L
    Cancer Detect Prev; 1985; 8(1-2):17-22. PubMed ID: 4064037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow up of thyroglobulin levels in patients with surgically treated, highly differentiated thyroid cancer].
    Szántó J; Vincze B; Sinkovits I; Karika Z; Daubner K; Péter I; Kazatsay I; Eckhardt S
    Orv Hetil; 1989 Aug; 130(32):1695-9. PubMed ID: 2780041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Schlumberger M
    J Nucl Med; 1992 Jan; 33(1):172-3. PubMed ID: 1571042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
    Feldt-Rasmussen U; Hansen HS; Rasmusson B
    Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
    Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
    J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroglobulin measurement in thyroid cancer.
    Lekkerkerker JF
    Neth J Med; 1985; 28(9):338-9. PubMed ID: 4047267
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum thyroglobulin measurements: clinical utility and technical limitations in the management of patients with differentiated thyroid carcinomas.
    Spencer CA
    Endocr Pract; 2000; 6(6):481-4. PubMed ID: 11155225
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum thyroglobulin in the follow-up of patients treated for differentiated carcinoma of the thyroid. Evaluation of factors determining its effectiveness].
    García Solís D; Rodríguez Rodríguez JR; Acosta D; Astorga R
    Med Clin (Barc); 1986 May; 86(18):748-52. PubMed ID: 3736171
    [No Abstract]   [Full Text] [Related]  

  • 15. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of thyroglobulin levels for survival in patients with differentiated carcinoma of the thyroid gland].
    Nĕmec J; Bílek R; Zamrazil V; Chytrý P; Vlcek P
    Cas Lek Cesk; 1997 Dec; 136(23):23-4. PubMed ID: 9476372
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of thyroglobulin determination in the follow-up of patients with papillary or follicular thyroid carcinoma].
    Hennemann G; Hennemann IP; Docter R; Krenning EP
    Ned Tijdschr Geneeskd; 1989 Mar; 133(10):491-3. PubMed ID: 2651932
    [No Abstract]   [Full Text] [Related]  

  • 18. [The value of serum thyroglobulin determination in the after-care of patients with differentiated thyroid neoplasms].
    Hüfner M; Pollmann H; Grussendorf M; Schenk P
    Schweiz Med Wochenschr; 1980 Feb; 110(5):159-62. PubMed ID: 7361086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroglobulin levels to follow-up patients with treated differentiated thyroid carcinoma.
    Moser E; Braun S; Büell U; Kirsch CM; Tosch U; Wendt T
    Cancer Detect Prev; 1984; 7(2):79-86. PubMed ID: 6424939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thyroglobulin levels: their use in monitoring thyroid carcinoma.
    Schwartz MA; Blahd WH
    Conn Med; 1982 Apr; 46(4):189. PubMed ID: 7105708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.